nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivermectin—ABCC1—Epirubicin—urinary bladder cancer	0.0708	0.0921	CbGbCtD
Ivermectin—ABCB1—Mitomycin—urinary bladder cancer	0.0648	0.0842	CbGbCtD
Ivermectin—ABCC1—Etoposide—urinary bladder cancer	0.0552	0.0717	CbGbCtD
Ivermectin—ABCC2—Carboplatin—urinary bladder cancer	0.0487	0.0632	CbGbCtD
Ivermectin—ABCG2—Fluorouracil—urinary bladder cancer	0.0443	0.0575	CbGbCtD
Ivermectin—ABCG2—Carboplatin—urinary bladder cancer	0.044	0.0572	CbGbCtD
Ivermectin—ABCC2—Cisplatin—urinary bladder cancer	0.0416	0.054	CbGbCtD
Ivermectin—ABCC2—Etoposide—urinary bladder cancer	0.0409	0.0531	CbGbCtD
Ivermectin—ABCC1—Doxorubicin—urinary bladder cancer	0.0376	0.0489	CbGbCtD
Ivermectin—ABCG2—Cisplatin—urinary bladder cancer	0.0376	0.0489	CbGbCtD
Ivermectin—ABCG2—Etoposide—urinary bladder cancer	0.0369	0.048	CbGbCtD
Ivermectin—ABCC1—Methotrexate—urinary bladder cancer	0.0365	0.0474	CbGbCtD
Ivermectin—CYP3A4—Thiotepa—urinary bladder cancer	0.0294	0.0382	CbGbCtD
Ivermectin—ABCC2—Doxorubicin—urinary bladder cancer	0.0279	0.0362	CbGbCtD
Ivermectin—ABCC2—Methotrexate—urinary bladder cancer	0.027	0.0351	CbGbCtD
Ivermectin—ABCG2—Doxorubicin—urinary bladder cancer	0.0252	0.0327	CbGbCtD
Ivermectin—ABCG2—Methotrexate—urinary bladder cancer	0.0244	0.0317	CbGbCtD
Ivermectin—ABCB1—Gemcitabine—urinary bladder cancer	0.0187	0.0242	CbGbCtD
Ivermectin—ABCB1—Cisplatin—urinary bladder cancer	0.0136	0.0176	CbGbCtD
Ivermectin—ABCB1—Etoposide—urinary bladder cancer	0.0133	0.0173	CbGbCtD
Ivermectin—ABCB1—Doxorubicin—urinary bladder cancer	0.00908	0.0118	CbGbCtD
Ivermectin—ABCB1—Methotrexate—urinary bladder cancer	0.0088	0.0114	CbGbCtD
Ivermectin—CYP3A4—Etoposide—urinary bladder cancer	0.00798	0.0104	CbGbCtD
Ivermectin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00544	0.00707	CbGbCtD
Ivermectin—NR1H4—prostate gland—urinary bladder cancer	0.00496	0.139	CbGeAlD
Ivermectin—NR1H4—renal system—urinary bladder cancer	0.00338	0.095	CbGeAlD
Ivermectin—NR1H4—female reproductive system—urinary bladder cancer	0.00271	0.0761	CbGeAlD
Ivermectin—CYP3A4—urine—urinary bladder cancer	0.00243	0.0682	CbGeAlD
Ivermectin—ABCC2—prostate gland—urinary bladder cancer	0.00171	0.0482	CbGeAlD
Ivermectin—GABRB3—prostate gland—urinary bladder cancer	0.0017	0.0478	CbGeAlD
Ivermectin—NR1H4—lymph node—urinary bladder cancer	0.00158	0.0445	CbGeAlD
Ivermectin—ABCC1—prostate gland—urinary bladder cancer	0.00151	0.0425	CbGeAlD
Ivermectin—ABCC1—seminal vesicle—urinary bladder cancer	0.00128	0.0359	CbGeAlD
Ivermectin—ABCG2—prostate gland—urinary bladder cancer	0.00125	0.0351	CbGeAlD
Ivermectin—ABCC2—renal system—urinary bladder cancer	0.00117	0.0328	CbGeAlD
Ivermectin—ABCG2—seminal vesicle—urinary bladder cancer	0.00106	0.0297	CbGeAlD
Ivermectin—ABCC1—urethra—urinary bladder cancer	0.00101	0.0284	CbGeAlD
Ivermectin—ABCC2—female reproductive system—urinary bladder cancer	0.000936	0.0263	CbGeAlD
Ivermectin—GABRB3—female reproductive system—urinary bladder cancer	0.000929	0.0261	CbGeAlD
Ivermectin—ABCG2—urethra—urinary bladder cancer	0.000837	0.0235	CbGeAlD
Ivermectin—ABCC1—vagina—urinary bladder cancer	0.000746	0.021	CbGeAlD
Ivermectin—ABCG2—vagina—urinary bladder cancer	0.000617	0.0173	CbGeAlD
Ivermectin—ABCB1—prostate gland—urinary bladder cancer	0.000617	0.0173	CbGeAlD
Ivermectin—CYP3A4—renal system—urinary bladder cancer	0.000594	0.0167	CbGeAlD
Ivermectin—ABCC2—lymph node—urinary bladder cancer	0.000548	0.0154	CbGeAlD
Ivermectin—ABCB1—seminal vesicle—urinary bladder cancer	0.000522	0.0147	CbGeAlD
Ivermectin—ABCC1—lymph node—urinary bladder cancer	0.000482	0.0136	CbGeAlD
Ivermectin—CYP3A4—female reproductive system—urinary bladder cancer	0.000476	0.0134	CbGeAlD
Ivermectin—ABCB1—epithelium—urinary bladder cancer	0.000453	0.0127	CbGeAlD
Ivermectin—ABCB1—renal system—urinary bladder cancer	0.00042	0.0118	CbGeAlD
Ivermectin—ABCB1—urethra—urinary bladder cancer	0.000413	0.0116	CbGeAlD
Ivermectin—ABCG2—lymph node—urinary bladder cancer	0.000399	0.0112	CbGeAlD
Ivermectin—ABCB1—female reproductive system—urinary bladder cancer	0.000337	0.00946	CbGeAlD
Ivermectin—ABCB1—vagina—urinary bladder cancer	0.000304	0.00856	CbGeAlD
Ivermectin—Vertigo—Etoposide—urinary bladder cancer	0.000264	0.00217	CcSEcCtD
Ivermectin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000264	0.00217	CcSEcCtD
Ivermectin—Body temperature increased—Thiotepa—urinary bladder cancer	0.000264	0.00217	CcSEcCtD
Ivermectin—Anorexia—Fluorouracil—urinary bladder cancer	0.000263	0.00216	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000263	0.00216	CcSEcCtD
Ivermectin—Leukopenia—Etoposide—urinary bladder cancer	0.000263	0.00216	CcSEcCtD
Ivermectin—Hypotension—Gemcitabine—urinary bladder cancer	0.000262	0.00216	CcSEcCtD
Ivermectin—Oedema—Cisplatin—urinary bladder cancer	0.000262	0.00215	CcSEcCtD
Ivermectin—Lethargy—Doxorubicin—urinary bladder cancer	0.000258	0.00212	CcSEcCtD
Ivermectin—Hypotension—Fluorouracil—urinary bladder cancer	0.000258	0.00212	CcSEcCtD
Ivermectin—Cough—Etoposide—urinary bladder cancer	0.000256	0.00211	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000256	0.0021	CcSEcCtD
Ivermectin—Tachycardia—Cisplatin—urinary bladder cancer	0.000255	0.0021	CcSEcCtD
Ivermectin—Convulsion—Etoposide—urinary bladder cancer	0.000254	0.00209	CcSEcCtD
Ivermectin—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000253	0.00208	CcSEcCtD
Ivermectin—Asthma—Methotrexate—urinary bladder cancer	0.000252	0.00208	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000251	0.00207	CcSEcCtD
Ivermectin—Dry skin—Epirubicin—urinary bladder cancer	0.000251	0.00206	CcSEcCtD
Ivermectin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00025	0.00206	CcSEcCtD
Ivermectin—Chest pain—Etoposide—urinary bladder cancer	0.00025	0.00206	CcSEcCtD
Ivermectin—Eosinophilia—Methotrexate—urinary bladder cancer	0.00025	0.00205	CcSEcCtD
Ivermectin—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00025	0.00205	CcSEcCtD
Ivermectin—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00025	0.00205	CcSEcCtD
Ivermectin—Somnolence—Gemcitabine—urinary bladder cancer	0.00025	0.00205	CcSEcCtD
Ivermectin—Anorexia—Cisplatin—urinary bladder cancer	0.000249	0.00205	CcSEcCtD
Ivermectin—Discomfort—Etoposide—urinary bladder cancer	0.000247	0.00203	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000246	0.00202	CcSEcCtD
Ivermectin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000246	0.00202	CcSEcCtD
Ivermectin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000246	0.00202	CcSEcCtD
Ivermectin—Somnolence—Fluorouracil—urinary bladder cancer	0.000245	0.00202	CcSEcCtD
Ivermectin—Hypotension—Cisplatin—urinary bladder cancer	0.000244	0.00201	CcSEcCtD
Ivermectin—Face oedema—Doxorubicin—urinary bladder cancer	0.000244	0.00201	CcSEcCtD
Ivermectin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000244	0.00201	CcSEcCtD
Ivermectin—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000242	0.00199	CcSEcCtD
Ivermectin—Fatigue—Gemcitabine—urinary bladder cancer	0.000242	0.00199	CcSEcCtD
Ivermectin—Confusional state—Etoposide—urinary bladder cancer	0.000242	0.00199	CcSEcCtD
Ivermectin—Constipation—Gemcitabine—urinary bladder cancer	0.00024	0.00197	CcSEcCtD
Ivermectin—Pain—Gemcitabine—urinary bladder cancer	0.00024	0.00197	CcSEcCtD
Ivermectin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00024	0.00197	CcSEcCtD
Ivermectin—Asthenia—Thiotepa—urinary bladder cancer	0.000239	0.00197	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000238	0.00196	CcSEcCtD
Ivermectin—Abdominal distension—Epirubicin—urinary bladder cancer	0.000238	0.00196	CcSEcCtD
Ivermectin—Asthma—Epirubicin—urinary bladder cancer	0.000236	0.00194	CcSEcCtD
Ivermectin—Pruritus—Thiotepa—urinary bladder cancer	0.000236	0.00194	CcSEcCtD
Ivermectin—Pain—Fluorouracil—urinary bladder cancer	0.000236	0.00194	CcSEcCtD
Ivermectin—Tachycardia—Etoposide—urinary bladder cancer	0.000234	0.00192	CcSEcCtD
Ivermectin—Eosinophilia—Epirubicin—urinary bladder cancer	0.000234	0.00192	CcSEcCtD
Ivermectin—Dyspnoea—Cisplatin—urinary bladder cancer	0.000233	0.00192	CcSEcCtD
Ivermectin—Dry skin—Doxorubicin—urinary bladder cancer	0.000232	0.00191	CcSEcCtD
Ivermectin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000232	0.0019	CcSEcCtD
Ivermectin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000231	0.0019	CcSEcCtD
Ivermectin—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000231	0.0019	CcSEcCtD
Ivermectin—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000231	0.0019	CcSEcCtD
Ivermectin—Anorexia—Etoposide—urinary bladder cancer	0.000228	0.00188	CcSEcCtD
Ivermectin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000228	0.00188	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000228	0.00187	CcSEcCtD
Ivermectin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000227	0.00187	CcSEcCtD
Ivermectin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000227	0.00187	CcSEcCtD
Ivermectin—Hypotension—Etoposide—urinary bladder cancer	0.000224	0.00184	CcSEcCtD
Ivermectin—Pain—Cisplatin—urinary bladder cancer	0.000224	0.00184	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000223	0.00183	CcSEcCtD
Ivermectin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000222	0.00182	CcSEcCtD
Ivermectin—Dizziness—Thiotepa—urinary bladder cancer	0.000221	0.00181	CcSEcCtD
Ivermectin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00022	0.00181	CcSEcCtD
Ivermectin—Urticaria—Fluorouracil—urinary bladder cancer	0.000219	0.0018	CcSEcCtD
Ivermectin—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000219	0.0018	CcSEcCtD
Ivermectin—Asthma—Doxorubicin—urinary bladder cancer	0.000219	0.0018	CcSEcCtD
Ivermectin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000218	0.00179	CcSEcCtD
Ivermectin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000216	0.00178	CcSEcCtD
Ivermectin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000216	0.00177	CcSEcCtD
Ivermectin—Haematuria—Methotrexate—urinary bladder cancer	0.000215	0.00176	CcSEcCtD
Ivermectin—Dyspnoea—Etoposide—urinary bladder cancer	0.000214	0.00176	CcSEcCtD
Ivermectin—Somnolence—Etoposide—urinary bladder cancer	0.000213	0.00175	CcSEcCtD
Ivermectin—Vomiting—Thiotepa—urinary bladder cancer	0.000212	0.00174	CcSEcCtD
Ivermectin—Rash—Thiotepa—urinary bladder cancer	0.00021	0.00173	CcSEcCtD
Ivermectin—Dermatitis—Thiotepa—urinary bladder cancer	0.00021	0.00173	CcSEcCtD
Ivermectin—Headache—Thiotepa—urinary bladder cancer	0.000209	0.00172	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000209	0.00172	CcSEcCtD
Ivermectin—Decreased appetite—Etoposide—urinary bladder cancer	0.000208	0.00171	CcSEcCtD
Ivermectin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000207	0.0017	CcSEcCtD
Ivermectin—Fatigue—Etoposide—urinary bladder cancer	0.000207	0.0017	CcSEcCtD
Ivermectin—Constipation—Etoposide—urinary bladder cancer	0.000205	0.00168	CcSEcCtD
Ivermectin—Pain—Etoposide—urinary bladder cancer	0.000205	0.00168	CcSEcCtD
Ivermectin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000205	0.00168	CcSEcCtD
Ivermectin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000203	0.00167	CcSEcCtD
Ivermectin—Hepatitis—Methotrexate—urinary bladder cancer	0.000202	0.00166	CcSEcCtD
Ivermectin—Asthenia—Gemcitabine—urinary bladder cancer	0.000201	0.00166	CcSEcCtD
Ivermectin—Haematuria—Epirubicin—urinary bladder cancer	0.000201	0.00165	CcSEcCtD
Ivermectin—Pruritus—Gemcitabine—urinary bladder cancer	0.000199	0.00163	CcSEcCtD
Ivermectin—Nausea—Thiotepa—urinary bladder cancer	0.000198	0.00163	CcSEcCtD
Ivermectin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000198	0.00162	CcSEcCtD
Ivermectin—ABCB1—lymph node—urinary bladder cancer	0.000197	0.00553	CbGeAlD
Ivermectin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000196	0.00161	CcSEcCtD
Ivermectin—Pruritus—Fluorouracil—urinary bladder cancer	0.000195	0.00161	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000193	0.00159	CcSEcCtD
Ivermectin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000193	0.00158	CcSEcCtD
Ivermectin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000192	0.00158	CcSEcCtD
Ivermectin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000191	0.00157	CcSEcCtD
Ivermectin—Urticaria—Etoposide—urinary bladder cancer	0.00019	0.00157	CcSEcCtD
Ivermectin—Body temperature increased—Etoposide—urinary bladder cancer	0.000189	0.00156	CcSEcCtD
Ivermectin—Abdominal pain—Etoposide—urinary bladder cancer	0.000189	0.00156	CcSEcCtD
Ivermectin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000189	0.00156	CcSEcCtD
Ivermectin—Hepatitis—Epirubicin—urinary bladder cancer	0.000189	0.00155	CcSEcCtD
Ivermectin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000189	0.00155	CcSEcCtD
Ivermectin—Asthenia—Cisplatin—urinary bladder cancer	0.000188	0.00154	CcSEcCtD
Ivermectin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000186	0.00153	CcSEcCtD
Ivermectin—Haematuria—Doxorubicin—urinary bladder cancer	0.000186	0.00153	CcSEcCtD
Ivermectin—Dizziness—Fluorouracil—urinary bladder cancer	0.000182	0.0015	CcSEcCtD
Ivermectin—Chills—Methotrexate—urinary bladder cancer	0.000181	0.00149	CcSEcCtD
Ivermectin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000179	0.00147	CcSEcCtD
Ivermectin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000179	0.00147	CcSEcCtD
Ivermectin—Vomiting—Gemcitabine—urinary bladder cancer	0.000178	0.00147	CcSEcCtD
Ivermectin—Rash—Gemcitabine—urinary bladder cancer	0.000177	0.00145	CcSEcCtD
Ivermectin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000177	0.00145	CcSEcCtD
Ivermectin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000177	0.00145	CcSEcCtD
Ivermectin—Headache—Gemcitabine—urinary bladder cancer	0.000176	0.00145	CcSEcCtD
Ivermectin—Vomiting—Fluorouracil—urinary bladder cancer	0.000175	0.00144	CcSEcCtD
Ivermectin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000175	0.00144	CcSEcCtD
Ivermectin—Rash—Fluorouracil—urinary bladder cancer	0.000174	0.00143	CcSEcCtD
Ivermectin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000174	0.00143	CcSEcCtD
Ivermectin—Headache—Fluorouracil—urinary bladder cancer	0.000173	0.00142	CcSEcCtD
Ivermectin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000172	0.00142	CcSEcCtD
Ivermectin—Asthenia—Etoposide—urinary bladder cancer	0.000172	0.00141	CcSEcCtD
Ivermectin—Back pain—Methotrexate—urinary bladder cancer	0.00017	0.0014	CcSEcCtD
Ivermectin—Chills—Epirubicin—urinary bladder cancer	0.00017	0.00139	CcSEcCtD
Ivermectin—Pruritus—Etoposide—urinary bladder cancer	0.00017	0.00139	CcSEcCtD
Ivermectin—Nausea—Gemcitabine—urinary bladder cancer	0.000167	0.00137	CcSEcCtD
Ivermectin—Vomiting—Cisplatin—urinary bladder cancer	0.000166	0.00137	CcSEcCtD
Ivermectin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000165	0.00136	CcSEcCtD
Ivermectin—Rash—Cisplatin—urinary bladder cancer	0.000165	0.00136	CcSEcCtD
Ivermectin—Dermatitis—Cisplatin—urinary bladder cancer	0.000165	0.00135	CcSEcCtD
Ivermectin—Diarrhoea—Etoposide—urinary bladder cancer	0.000164	0.00135	CcSEcCtD
Ivermectin—Nausea—Fluorouracil—urinary bladder cancer	0.000164	0.00135	CcSEcCtD
Ivermectin—Anaemia—Methotrexate—urinary bladder cancer	0.000163	0.00134	CcSEcCtD
Ivermectin—Back pain—Epirubicin—urinary bladder cancer	0.000159	0.00131	CcSEcCtD
Ivermectin—Dizziness—Etoposide—urinary bladder cancer	0.000158	0.0013	CcSEcCtD
Ivermectin—Vertigo—Methotrexate—urinary bladder cancer	0.000158	0.0013	CcSEcCtD
Ivermectin—Leukopenia—Methotrexate—urinary bladder cancer	0.000157	0.00129	CcSEcCtD
Ivermectin—Chills—Doxorubicin—urinary bladder cancer	0.000157	0.00129	CcSEcCtD
Ivermectin—Nausea—Cisplatin—urinary bladder cancer	0.000155	0.00128	CcSEcCtD
Ivermectin—Cough—Methotrexate—urinary bladder cancer	0.000154	0.00126	CcSEcCtD
Ivermectin—Convulsion—Methotrexate—urinary bladder cancer	0.000152	0.00125	CcSEcCtD
Ivermectin—Vomiting—Etoposide—urinary bladder cancer	0.000152	0.00125	CcSEcCtD
Ivermectin—Anaemia—Epirubicin—urinary bladder cancer	0.000152	0.00125	CcSEcCtD
Ivermectin—Rash—Etoposide—urinary bladder cancer	0.000151	0.00124	CcSEcCtD
Ivermectin—Dermatitis—Etoposide—urinary bladder cancer	0.000151	0.00124	CcSEcCtD
Ivermectin—Headache—Etoposide—urinary bladder cancer	0.00015	0.00123	CcSEcCtD
Ivermectin—Arthralgia—Methotrexate—urinary bladder cancer	0.00015	0.00123	CcSEcCtD
Ivermectin—Myalgia—Methotrexate—urinary bladder cancer	0.00015	0.00123	CcSEcCtD
Ivermectin—Chest pain—Methotrexate—urinary bladder cancer	0.00015	0.00123	CcSEcCtD
Ivermectin—Discomfort—Methotrexate—urinary bladder cancer	0.000148	0.00122	CcSEcCtD
Ivermectin—Vertigo—Epirubicin—urinary bladder cancer	0.000148	0.00122	CcSEcCtD
Ivermectin—Leukopenia—Epirubicin—urinary bladder cancer	0.000147	0.00121	CcSEcCtD
Ivermectin—Back pain—Doxorubicin—urinary bladder cancer	0.000147	0.00121	CcSEcCtD
Ivermectin—Confusional state—Methotrexate—urinary bladder cancer	0.000145	0.00119	CcSEcCtD
Ivermectin—Cough—Epirubicin—urinary bladder cancer	0.000144	0.00118	CcSEcCtD
Ivermectin—Convulsion—Epirubicin—urinary bladder cancer	0.000143	0.00117	CcSEcCtD
Ivermectin—Nausea—Etoposide—urinary bladder cancer	0.000142	0.00117	CcSEcCtD
Ivermectin—Anaemia—Doxorubicin—urinary bladder cancer	0.000141	0.00116	CcSEcCtD
Ivermectin—Arthralgia—Epirubicin—urinary bladder cancer	0.00014	0.00115	CcSEcCtD
Ivermectin—Chest pain—Epirubicin—urinary bladder cancer	0.00014	0.00115	CcSEcCtD
Ivermectin—Myalgia—Epirubicin—urinary bladder cancer	0.00014	0.00115	CcSEcCtD
Ivermectin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000139	0.00114	CcSEcCtD
Ivermectin—Discomfort—Epirubicin—urinary bladder cancer	0.000138	0.00114	CcSEcCtD
Ivermectin—Vertigo—Doxorubicin—urinary bladder cancer	0.000137	0.00113	CcSEcCtD
Ivermectin—Anorexia—Methotrexate—urinary bladder cancer	0.000137	0.00112	CcSEcCtD
Ivermectin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000136	0.00112	CcSEcCtD
Ivermectin—Confusional state—Epirubicin—urinary bladder cancer	0.000135	0.00111	CcSEcCtD
Ivermectin—Oedema—Epirubicin—urinary bladder cancer	0.000134	0.0011	CcSEcCtD
Ivermectin—Hypotension—Methotrexate—urinary bladder cancer	0.000134	0.0011	CcSEcCtD
Ivermectin—Cough—Doxorubicin—urinary bladder cancer	0.000133	0.00109	CcSEcCtD
Ivermectin—Convulsion—Doxorubicin—urinary bladder cancer	0.000132	0.00108	CcSEcCtD
Ivermectin—Tachycardia—Epirubicin—urinary bladder cancer	0.000131	0.00108	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000131	0.00108	CcSEcCtD
Ivermectin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00013	0.00107	CcSEcCtD
Ivermectin—Arthralgia—Doxorubicin—urinary bladder cancer	0.00013	0.00107	CcSEcCtD
Ivermectin—Myalgia—Doxorubicin—urinary bladder cancer	0.00013	0.00107	CcSEcCtD
Ivermectin—Chest pain—Doxorubicin—urinary bladder cancer	0.00013	0.00107	CcSEcCtD
Ivermectin—Discomfort—Doxorubicin—urinary bladder cancer	0.000128	0.00105	CcSEcCtD
Ivermectin—Anorexia—Epirubicin—urinary bladder cancer	0.000128	0.00105	CcSEcCtD
Ivermectin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000128	0.00105	CcSEcCtD
Ivermectin—Somnolence—Methotrexate—urinary bladder cancer	0.000128	0.00105	CcSEcCtD
Ivermectin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000126	0.00172	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PRSS3—urinary bladder cancer	0.000126	0.00172	CbGpPWpGaD
Ivermectin—Hypotension—Epirubicin—urinary bladder cancer	0.000126	0.00103	CcSEcCtD
Ivermectin—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000125	0.00171	CbGpPWpGaD
Ivermectin—Confusional state—Doxorubicin—urinary bladder cancer	0.000125	0.00103	CcSEcCtD
Ivermectin—ABCC1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000125	0.00171	CbGpPWpGaD
Ivermectin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	0.000125	0.0017	CbGpPWpGaD
Ivermectin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000125	0.00103	CcSEcCtD
Ivermectin—Oedema—Doxorubicin—urinary bladder cancer	0.000124	0.00102	CcSEcCtD
Ivermectin—Fatigue—Methotrexate—urinary bladder cancer	0.000124	0.00102	CcSEcCtD
Ivermectin—Pain—Methotrexate—urinary bladder cancer	0.000123	0.00101	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000122	0.00101	CcSEcCtD
Ivermectin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000121	0.000997	CcSEcCtD
Ivermectin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00012	0.000988	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.00012	0.00164	CbGpPWpGaD
Ivermectin—Dyspnoea—Epirubicin—urinary bladder cancer	0.00012	0.000985	CcSEcCtD
Ivermectin—Somnolence—Epirubicin—urinary bladder cancer	0.000119	0.000982	CcSEcCtD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000119	0.00163	CbGpPWpGaD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000119	0.00162	CbGpPWpGaD
Ivermectin—Anorexia—Doxorubicin—urinary bladder cancer	0.000118	0.000974	CcSEcCtD
Ivermectin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000118	0.000973	CcSEcCtD
Ivermectin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000117	0.000965	CcSEcCtD
Ivermectin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000117	0.00096	CcSEcCtD
Ivermectin—Hypotension—Doxorubicin—urinary bladder cancer	0.000116	0.000955	CcSEcCtD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000116	0.00158	CbGpPWpGaD
Ivermectin—Fatigue—Epirubicin—urinary bladder cancer	0.000116	0.000952	CcSEcCtD
Ivermectin—Pain—Epirubicin—urinary bladder cancer	0.000115	0.000944	CcSEcCtD
Ivermectin—Constipation—Epirubicin—urinary bladder cancer	0.000115	0.000944	CcSEcCtD
Ivermectin—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000115	0.00156	CbGpPWpGaD
Ivermectin—Urticaria—Methotrexate—urinary bladder cancer	0.000114	0.000938	CcSEcCtD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000114	0.00156	CbGpPWpGaD
Ivermectin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000113	0.000933	CcSEcCtD
Ivermectin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000113	0.000933	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000113	0.000931	CcSEcCtD
Ivermectin—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000113	0.00154	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000113	0.00154	CbGpPWpGaD
Ivermectin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000111	0.000911	CcSEcCtD
Ivermectin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000111	0.00091	CcSEcCtD
Ivermectin—Somnolence—Doxorubicin—urinary bladder cancer	0.000111	0.000909	CcSEcCtD
Ivermectin—ABCG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00011	0.0015	CbGpPWpGaD
Ivermectin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00011	0.000903	CcSEcCtD
Ivermectin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000108	0.000888	CcSEcCtD
Ivermectin—Fatigue—Doxorubicin—urinary bladder cancer	0.000107	0.000881	CcSEcCtD
Ivermectin—Urticaria—Epirubicin—urinary bladder cancer	0.000107	0.000877	CcSEcCtD
Ivermectin—Constipation—Doxorubicin—urinary bladder cancer	0.000106	0.000874	CcSEcCtD
Ivermectin—Pain—Doxorubicin—urinary bladder cancer	0.000106	0.000874	CcSEcCtD
Ivermectin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000106	0.000873	CcSEcCtD
Ivermectin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000106	0.000873	CcSEcCtD
Ivermectin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000106	0.00087	CcSEcCtD
Ivermectin—ABCC2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000103	0.00141	CbGpPWpGaD
Ivermectin—Asthenia—Methotrexate—urinary bladder cancer	0.000103	0.000847	CcSEcCtD
Ivermectin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000102	0.000842	CcSEcCtD
Ivermectin—ABCC1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000102	0.00139	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000102	0.00139	CbGpPWpGaD
Ivermectin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000102	0.000836	CcSEcCtD
Ivermectin—Pruritus—Methotrexate—urinary bladder cancer	0.000102	0.000835	CcSEcCtD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000101	0.00138	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—TYMP—urinary bladder cancer	0.000101	0.00137	CbGpPWpGaD
Ivermectin—Hypersensitivity—Epirubicin—urinary bladder cancer	9.9e-05	0.000814	CcSEcCtD
Ivermectin—Urticaria—Doxorubicin—urinary bladder cancer	9.88e-05	0.000812	CcSEcCtD
Ivermectin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	9.87e-05	0.00135	CbGpPWpGaD
Ivermectin—Abdominal pain—Doxorubicin—urinary bladder cancer	9.83e-05	0.000808	CcSEcCtD
Ivermectin—Body temperature increased—Doxorubicin—urinary bladder cancer	9.83e-05	0.000808	CcSEcCtD
Ivermectin—Diarrhoea—Methotrexate—urinary bladder cancer	9.82e-05	0.000808	CcSEcCtD
Ivermectin—ABCC1—Disease—GSTO2—urinary bladder cancer	9.69e-05	0.00132	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.67e-05	0.00132	CbGpPWpGaD
Ivermectin—Asthenia—Epirubicin—urinary bladder cancer	9.64e-05	0.000792	CcSEcCtD
Ivermectin—Pruritus—Epirubicin—urinary bladder cancer	9.51e-05	0.000781	CcSEcCtD
Ivermectin—Dizziness—Methotrexate—urinary bladder cancer	9.49e-05	0.00078	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—ESR1—urinary bladder cancer	9.44e-05	0.00129	CbGpPWpGaD
Ivermectin—Diarrhoea—Epirubicin—urinary bladder cancer	9.19e-05	0.000756	CcSEcCtD
Ivermectin—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.16e-05	0.000753	CcSEcCtD
Ivermectin—Vomiting—Methotrexate—urinary bladder cancer	9.13e-05	0.00075	CcSEcCtD
Ivermectin—NR1H4—Metabolism—NAT2—urinary bladder cancer	9.11e-05	0.00124	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	9.09e-05	0.00124	CbGpPWpGaD
Ivermectin—Rash—Methotrexate—urinary bladder cancer	9.05e-05	0.000744	CcSEcCtD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	9.05e-05	0.00124	CbGpPWpGaD
Ivermectin—Dermatitis—Methotrexate—urinary bladder cancer	9.04e-05	0.000743	CcSEcCtD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	9.04e-05	0.00123	CbGpPWpGaD
Ivermectin—Headache—Methotrexate—urinary bladder cancer	8.99e-05	0.000739	CcSEcCtD
Ivermectin—ABCG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.99e-05	0.00123	CbGpPWpGaD
Ivermectin—Asthenia—Doxorubicin—urinary bladder cancer	8.92e-05	0.000733	CcSEcCtD
Ivermectin—Dizziness—Epirubicin—urinary bladder cancer	8.88e-05	0.00073	CcSEcCtD
Ivermectin—Pruritus—Doxorubicin—urinary bladder cancer	8.8e-05	0.000723	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—PPARG—urinary bladder cancer	8.61e-05	0.00117	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—SMC1A—urinary bladder cancer	8.59e-05	0.00117	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GSTZ1—urinary bladder cancer	8.56e-05	0.00117	CbGpPWpGaD
Ivermectin—Vomiting—Epirubicin—urinary bladder cancer	8.54e-05	0.000702	CcSEcCtD
Ivermectin—Nausea—Methotrexate—urinary bladder cancer	8.53e-05	0.000701	CcSEcCtD
Ivermectin—Diarrhoea—Doxorubicin—urinary bladder cancer	8.51e-05	0.000699	CcSEcCtD
Ivermectin—Rash—Epirubicin—urinary bladder cancer	8.47e-05	0.000696	CcSEcCtD
Ivermectin—Dermatitis—Epirubicin—urinary bladder cancer	8.46e-05	0.000696	CcSEcCtD
Ivermectin—Headache—Epirubicin—urinary bladder cancer	8.42e-05	0.000692	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—CREBBP—urinary bladder cancer	8.27e-05	0.00113	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	8.24e-05	0.00113	CbGpPWpGaD
Ivermectin—Dizziness—Doxorubicin—urinary bladder cancer	8.22e-05	0.000676	CcSEcCtD
Ivermectin—ABCC1—Metabolism—GSTO2—urinary bladder cancer	8.12e-05	0.00111	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—NAT1—urinary bladder cancer	8.12e-05	0.00111	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.98e-05	0.00109	CbGpPWpGaD
Ivermectin—Nausea—Epirubicin—urinary bladder cancer	7.98e-05	0.000656	CcSEcCtD
Ivermectin—Vomiting—Doxorubicin—urinary bladder cancer	7.9e-05	0.00065	CcSEcCtD
Ivermectin—NR1H4—Metabolism—RRM2—urinary bladder cancer	7.86e-05	0.00107	CbGpPWpGaD
Ivermectin—Rash—Doxorubicin—urinary bladder cancer	7.84e-05	0.000644	CcSEcCtD
Ivermectin—Dermatitis—Doxorubicin—urinary bladder cancer	7.83e-05	0.000644	CcSEcCtD
Ivermectin—Headache—Doxorubicin—urinary bladder cancer	7.79e-05	0.00064	CcSEcCtD
Ivermectin—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.62e-05	0.00104	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	7.62e-05	0.00104	CbGpPWpGaD
Ivermectin—ABCC1—Disease—SLC19A1—urinary bladder cancer	7.54e-05	0.00103	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GSTZ1—urinary bladder cancer	7.53e-05	0.00103	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	7.52e-05	0.00103	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—ESR2—urinary bladder cancer	7.49e-05	0.00102	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	7.46e-05	0.00102	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—UGT2B7—urinary bladder cancer	7.42e-05	0.00101	CbGpPWpGaD
Ivermectin—Nausea—Doxorubicin—urinary bladder cancer	7.38e-05	0.000607	CcSEcCtD
Ivermectin—ABCC1—Disease—PRSS3—urinary bladder cancer	7.34e-05	0.001	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—HPGDS—urinary bladder cancer	7.28e-05	0.000993	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—ENO2—urinary bladder cancer	7.28e-05	0.000993	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	7.28e-05	0.000993	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.24e-05	0.000988	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GSTO2—urinary bladder cancer	7.14e-05	0.000975	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—NAT1—urinary bladder cancer	7.14e-05	0.000975	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GSTT1—urinary bladder cancer	7.06e-05	0.000964	CbGpPWpGaD
Ivermectin—ABCC1—Disease—HDAC4—urinary bladder cancer	7.01e-05	0.000956	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.98e-05	0.000953	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.95e-05	0.000949	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.9e-05	0.000941	CbGpPWpGaD
Ivermectin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	6.82e-05	0.00093	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CYP4B1—urinary bladder cancer	6.68e-05	0.000912	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.61e-05	0.000902	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—UGT2B7—urinary bladder cancer	6.53e-05	0.000891	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—SLC19A1—urinary bladder cancer	6.31e-05	0.000861	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	6.22e-05	0.00085	CbGpPWpGaD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	6.16e-05	0.000841	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PRSS3—urinary bladder cancer	6.15e-05	0.000839	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	6.09e-05	0.000831	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.07e-05	0.000828	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	5.96e-05	0.000813	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	5.95e-05	0.000812	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	5.91e-05	0.000806	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CYP4B1—urinary bladder cancer	5.88e-05	0.000803	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—NQO1—urinary bladder cancer	5.87e-05	0.000801	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	5.79e-05	0.00079	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—NCOR1—urinary bladder cancer	5.78e-05	0.000789	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.69e-05	0.000777	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	5.68e-05	0.000776	CbGpPWpGaD
Ivermectin—ABCC1—Disease—LIG1—urinary bladder cancer	5.57e-05	0.00076	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—SLC19A1—urinary bladder cancer	5.55e-05	0.000758	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—ERCC2—urinary bladder cancer	5.44e-05	0.000742	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PRSS3—urinary bladder cancer	5.41e-05	0.000739	CbGpPWpGaD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.37e-05	0.000733	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	5.25e-05	0.000716	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	5.04e-05	0.000687	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.96e-05	0.000678	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.93e-05	0.000673	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—TYMP—urinary bladder cancer	4.92e-05	0.000671	CbGpPWpGaD
Ivermectin—NR1H4—Generic Transcription Pathway—MYC—urinary bladder cancer	4.91e-05	0.00067	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GSTP1—urinary bladder cancer	4.89e-05	0.000668	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.86e-05	0.000663	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.73e-05	0.000646	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.72e-05	0.000644	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—TYMS—urinary bladder cancer	4.55e-05	0.000621	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—ESR1—urinary bladder cancer	4.54e-05	0.00062	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—NCOR1—urinary bladder cancer	4.5e-05	0.000614	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GSTM1—urinary bladder cancer	4.5e-05	0.000614	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.45e-05	0.000607	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—NAT2—urinary bladder cancer	4.45e-05	0.000607	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.43e-05	0.000605	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.41e-05	0.000602	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	4.33e-05	0.000591	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—TYMP—urinary bladder cancer	4.33e-05	0.00059	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GPX1—urinary bladder cancer	4.31e-05	0.000588	CbGpPWpGaD
Ivermectin—ABCC1—Disease—ENO2—urinary bladder cancer	4.24e-05	0.000579	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—ERCC2—urinary bladder cancer	4.23e-05	0.000577	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—PPARG—urinary bladder cancer	4.14e-05	0.000566	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.1e-05	0.000559	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	4.07e-05	0.000556	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.04e-05	0.000551	CbGpPWpGaD
Ivermectin—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.04e-05	0.000551	CbGpPWpGaD
Ivermectin—ABCC1—Disease—RBX1—urinary bladder cancer	4.02e-05	0.000549	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—CREBBP—urinary bladder cancer	3.98e-05	0.000543	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—MTHFR—urinary bladder cancer	3.97e-05	0.000542	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—NAT2—urinary bladder cancer	3.91e-05	0.000534	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.87e-05	0.000528	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.86e-05	0.000527	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.86e-05	0.000527	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—RRM2—urinary bladder cancer	3.84e-05	0.000524	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.82e-05	0.000521	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	3.76e-05	0.000514	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.71e-05	0.000507	CbGpPWpGaD
Ivermectin—ABCC1—Disease—JAG1—urinary bladder cancer	3.6e-05	0.000492	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.57e-05	0.000487	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—HPGDS—urinary bladder cancer	3.55e-05	0.000485	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—ENO2—urinary bladder cancer	3.55e-05	0.000485	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.53e-05	0.000482	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.53e-05	0.000482	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GSTT1—urinary bladder cancer	3.45e-05	0.000471	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.4e-05	0.000463	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—RRM2—urinary bladder cancer	3.38e-05	0.000461	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.28e-05	0.000448	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.27e-05	0.000446	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.24e-05	0.000442	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.23e-05	0.000441	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PPARG—urinary bladder cancer	3.22e-05	0.00044	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.18e-05	0.000434	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.17e-05	0.000432	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—ENO2—urinary bladder cancer	3.13e-05	0.000427	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—HPGDS—urinary bladder cancer	3.13e-05	0.000427	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—CREBBP—urinary bladder cancer	3.1e-05	0.000423	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—HRAS—urinary bladder cancer	3.09e-05	0.000422	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GSTT1—urinary bladder cancer	3.03e-05	0.000414	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3e-05	0.00041	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.93e-05	0.000399	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—NQO1—urinary bladder cancer	2.87e-05	0.000391	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.86e-05	0.000391	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.84e-05	0.000388	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.78e-05	0.000379	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.77e-05	0.000378	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.76e-05	0.000377	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.63e-05	0.00036	CbGpPWpGaD
Ivermectin—ABCC1—Disease—NCOR1—urinary bladder cancer	2.62e-05	0.000358	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.56e-05	0.00035	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PTGS2—urinary bladder cancer	2.54e-05	0.000346	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—NQO1—urinary bladder cancer	2.52e-05	0.000344	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.51e-05	0.000342	CbGpPWpGaD
Ivermectin—ABCC1—Disease—ERCC2—urinary bladder cancer	2.47e-05	0.000336	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.42e-05	0.000331	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GSTP1—urinary bladder cancer	2.39e-05	0.000326	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.38e-05	0.000325	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.38e-05	0.000325	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—MYC—urinary bladder cancer	2.36e-05	0.000322	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.34e-05	0.000319	CbGpPWpGaD
Ivermectin—ABCC1—Disease—MTHFR—urinary bladder cancer	2.32e-05	0.000316	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.31e-05	0.000316	CbGpPWpGaD
Ivermectin—ABCC1—Disease—TERT—urinary bladder cancer	2.31e-05	0.000315	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.3e-05	0.000313	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.25e-05	0.000306	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—TYMS—urinary bladder cancer	2.22e-05	0.000303	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PTEN—urinary bladder cancer	2.21e-05	0.000302	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—NCOR1—urinary bladder cancer	2.2e-05	0.0003	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GSTM1—urinary bladder cancer	2.2e-05	0.0003	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.18e-05	0.000297	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.14e-05	0.000292	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.12e-05	0.000289	CbGpPWpGaD
Ivermectin—ABCC1—Disease—FGFR3—urinary bladder cancer	2.12e-05	0.000289	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.12e-05	0.000289	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—EP300—urinary bladder cancer	2.11e-05	0.000288	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GPX1—urinary bladder cancer	2.1e-05	0.000287	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GSTP1—urinary bladder cancer	2.1e-05	0.000287	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—ERCC2—urinary bladder cancer	2.06e-05	0.000282	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.96e-05	0.000267	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.96e-05	0.000267	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—MTHFR—urinary bladder cancer	1.94e-05	0.000265	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.93e-05	0.000264	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.93e-05	0.000264	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.89e-05	0.000257	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.85e-05	0.000253	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.85e-05	0.000252	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.83e-05	0.000249	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.82e-05	0.000248	CbGpPWpGaD
Ivermectin—ABCC1—Disease—CREBBP—urinary bladder cancer	1.81e-05	0.000246	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.8e-05	0.000246	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.71e-05	0.000233	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.69e-05	0.000231	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.69e-05	0.000231	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.64e-05	0.000224	CbGpPWpGaD
Ivermectin—ABCC1—Disease—RHOA—urinary bladder cancer	1.63e-05	0.000223	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PPARG—urinary bladder cancer	1.57e-05	0.000215	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.54e-05	0.00021	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CREBBP—urinary bladder cancer	1.51e-05	0.000206	CbGpPWpGaD
Ivermectin—ABCC1—Disease—ERBB2—urinary bladder cancer	1.51e-05	0.000206	CbGpPWpGaD
Ivermectin—ABCC1—Disease—PTGS2—urinary bladder cancer	1.48e-05	0.000202	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.44e-05	0.000197	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PPARG—urinary bladder cancer	1.38e-05	0.000189	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.36e-05	0.000186	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.33e-05	0.000182	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.3e-05	0.000178	CbGpPWpGaD
Ivermectin—ABCC1—Disease—CDKN1A—urinary bladder cancer	1.29e-05	0.000176	CbGpPWpGaD
Ivermectin—ABCC1—Disease—PTEN—urinary bladder cancer	1.29e-05	0.000176	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PTGS2—urinary bladder cancer	1.24e-05	0.000169	CbGpPWpGaD
Ivermectin—ABCC1—Disease—EP300—urinary bladder cancer	1.23e-05	0.000168	CbGpPWpGaD
Ivermectin—ABCC1—Disease—SRC—urinary bladder cancer	1.2e-05	0.000163	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.14e-05	0.000155	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.13e-05	0.000154	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.09e-05	0.000149	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PTEN—urinary bladder cancer	1.08e-05	0.000147	CbGpPWpGaD
Ivermectin—ABCC1—Disease—MYC—urinary bladder cancer	1.07e-05	0.000146	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.06e-05	0.000144	CbGpPWpGaD
Ivermectin—ABCC1—Disease—EGFR—urinary bladder cancer	1.05e-05	0.000143	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.04e-05	0.000143	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.04e-05	0.000143	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.04e-05	0.000142	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.04e-05	0.000142	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—EP300—urinary bladder cancer	1.03e-05	0.000141	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.01e-05	0.000138	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GPX1—urinary bladder cancer	1e-05	0.000137	CbGpPWpGaD
Ivermectin—ABCC1—Disease—KRAS—urinary bladder cancer	9.9e-06	0.000135	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.82e-06	0.000134	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PTEN—urinary bladder cancer	9.5e-06	0.00013	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	9.23e-06	0.000126	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—EP300—urinary bladder cancer	9.06e-06	0.000124	CbGpPWpGaD
Ivermectin—ABCC1—Disease—HRAS—urinary bladder cancer	8.42e-06	0.000115	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	8.4e-06	0.000115	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.49e-06	0.000102	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	7.19e-06	9.82e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7e-06	9.56e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.51e-06	8.89e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.44e-06	8.79e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.44e-06	8.79e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.16e-06	8.41e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.05e-06	8.26e-05	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.89e-06	8.04e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.69e-06	7.76e-05	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.14e-06	7.01e-05	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—EP300—urinary bladder cancer	4.9e-06	6.69e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.61e-06	6.3e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.43e-06	6.05e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.63e-06	4.95e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.16e-06	4.32e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.02e-06	4.12e-05	CbGpPWpGaD
